General Information of Drug (ID: DMXB7V8)

Drug Name
Naxitamab
Indication
Disease Entry ICD 11 Status REF
Neuroblastoma 2D11.2 Approved [1]
Osteosarcoma 2B51 Phase 2 [2]
Cross-matching ID
TTD ID
D0HI5D
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

References

1 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services. 2020
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)